Showing results (51-60 of 247) with videos related to
Sort By:
Pageof 25
Oncogene|August 2, 2003
Role of IFI 16, a member of the interferon-inducible p200-protein family, in prostate epithelial cellular senescenceHong Xin, Jonathan Curry, Ricky W Johnstone, et al.Oncoimmunology|June 28, 2012
The combination of histone deacetylase inhibitors with immune-stimulating antibodies has potent anti-cancer effectsAlison C West, Ailsa J Christiansen, Mark J Smyth, et al.Internal Medicine Journal|October 19, 2021
Prediction of cardiovascular events in patients with chronic myeloid leukaemia using baseline risk factors and coronary artery calcium scoringDiva Baggio, Sean Tan, Kylie Porch, et al.Nature Reviews. Drug Discovery|September 15, 2020
Targeting the epigenetic regulation of antitumour immunitySimon J Hogg, Paul A Beavis, Mark A Dawson, et al.Oncogene|August 11, 2005
Epigenetic changes to the MDR1 locus in response to chemotherapeutic drugsEmma K Baker, Ricky W Johnstone, John R Zalcberg, et al.Transfusion|August 29, 2025
Red blood cell transfusion practice and cardiac comorbidities in patients with myelodysplastic syndromesAllison Mo, Erica M Wood, Jake Shortt, et al.Journal of the National Comprehensive Cancer Network : JNCCN|August 7, 2023
Hematologic Malignancy: Who Cares in the End? A Retrospective Cohort Study of Markers of Quality End-of-Life CareBriony Shaw, Catriona Parker, Stephen Opat, et al.European Journal of Haematology|July 15, 2023
Platelet transfusions and predictors of bleeding in patients with myelodysplastic syndromesAllison Mo, Erica Wood, Jake Shortt, et al.Proceedings of the National Academy of Sciences of the United States of America|August 29, 2023
Rationally designed chimeric PI3K-BET bromodomain inhibitors elicit curative responses in MYC-driven lymphomaDanielle H Oh, Xiao Ma, Simon J Hogg, et al.Oncoimmunology|December 25, 2012
Enhancing the antitumor effects of radiotherapy with combinations of immunostimulatory antibodiesInge Verbrugge, Mara Galli, Mark J Smyth, et al.Pageof 25